Begin main content

Tesamorelin

Last Updated: February 4, 2016
Result type: Reports
Project Number: SR0477-000
Product Line: Common Drug Review

Generic Name: Tesamorelin

Brand Name: Egrifta

Manufacturer: Theratechnologies Inc.

Indications: Lipodystrophy, HIV-infected patients

Submission Type: New

Project Status: Active

Date Recommendation Issued: August 24, 2016

Recommendation Type: Do not reimburse

Tags

lipodystrophy, hiv/aids, infectious diseases